Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Tesofensine structure

Tesofensine

Metabolic
Phase 2 Research
55%
Moderate Risk
3/5

Warnings

Cardiovascular risks - monitor BP and HR
Psychiatric effects possible
Serotonin syndrome risk with SSRIs
Not FDA approved
Phase III trials ongoing

Contraindications

MAO InhibitorsUncontrolled HypertensionCardiovascular DiseaseHyperthyroidismGlaucomaPregnancyBreastfeeding

Drug Interactions

MAOIsSSRIsSNRIsStimulantsSympathomimeticsCYP3A4 Inhibitors

Possible Side Effects

Dry MouthConstipationInsomniaIncreased Heart RateElevated Blood PressureMood Changes

Legal & Regulatory

FDA Status Not FDA Approved
WADA Status Prohibited in Sport
Prescription Required

Pregnancy

Category X - Contraindicated